Lista de obras -

A composite measure of cognitive and functional progression in Alzheimer's disease: Design of the Capturing Changes in Cognition study

artículo científico publicado en 2017

A novel cognitive-functional composite measure to detect changes in early Alzheimer's disease: Test-retest reliability and feasibility.

artículo científico publicado en 2017

A phase 2 randomized, controlled trial of the α7 agonist ABT-126 in mild-to-moderate Alzheimer's dementia.

artículo científico publicado en 2015

A randomized, double-blind, placebo-controlled trial of donepezil hydrochloride (Aricept) for reducing the incidence of postoperative delirium after elective total hip replacement

artículo científico publicado en 2007

A randomized, exploratory molecular imaging study targeting amyloid β with a novel 8-OH quinoline in Alzheimer's disease: The PBT2-204 IMAGINE study

artículo científico publicado en 2017

A review of clinical trial designs used to detect a disease-modifying effect of drug therapy in Alzheimer's disease and Parkinson's disease

artículo científico publicado en 2016

A systematic review of biomarkers for disease progression in Alzheimer's disease

artículo científico publicado en 2014

ABT-126 monotherapy in mild-to-moderate Alzheimer's dementia: randomized double-blind, placebo and active controlled adaptive trial and open-label extension

artículo científico publicado en 2016

Alcohol and Alzheimer's Disease-Does Alcohol Dependence Contribute to Beta-Amyloid Deposition, Neuroinflammation and Neurodegeneration in Alzheimer's Disease?

artículo científico publicado en 2016

Alcohol and Alzheimer's Disease-Does Alcohol Dependence Contribute to Beta-Amyloid Deposition, Neuroinflammation and Neurodegeneration in Alzheimer's Disease?

artículo científico publicado en 2017

Alzheimer's disease in Down syndrome: An overlooked population for prevention trials

scholarly article by Andre Strydom et al published 2018 in Alzheimer's & dementia (New York, N. Y.)

Amisulpride for very late-onset schizophrenia-like psychosis: the ATLAS three-arm RCT

scientific article published on 01 November 2018

An international perspective on advanced neuroimaging: cometh the hour or ivory tower?

artículo científico

An international perspective on advanced neuroimaging: cometh the hour or ivory tower? – Corrigendum

scholarly article published in International Psychogeriatrics

Antipsychotic treatment of very late-onset schizophrenia-like psychosis (ATLAS): a randomised, controlled, double-blind trial.

artículo científico publicado en 2018

Aβ42/Aβ40 and Aβ42/Aβ38 Ratios Are Associated with Measures of Gait Variability and Activities of Daily Living in Mild Alzheimer's Disease: A Pilot Study

scholarly article by Ivan Koychev et al published 2018 in Journal of Alzheimer's Disease

Better together for better dementia research and care

artículo científico publicado en 2016

Boosting translational research on Alzheimer's disease in Europe: The Innovative Medicine Initiative AD research platform

artículo científico publicado en 2015

CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)

artículo científico publicado en 1996

CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).

artículo científico publicado en 2017

Carer impressions of participation in Alzheimer's disease clinical trials: what are their hopes? And is it worth it?

artículo científico publicado en 2002

Change in Health-related Quality of Life After Referral to Memory Assessment Services

artículo científico publicado en 2017

Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology

artículo científico publicado en 2006

Dementia trials and dementia tribulations: methodological and analytical challenges in dementia research

artículo científico publicado en 2015

Detecting cognitive changes in preclinical Alzheimer's disease: A review of its feasibility

artículo científico

Development of interventions for the secondary prevention of Alzheimer's dementia: the European Prevention of Alzheimer's Dementia (EPAD) project

artículo científico

Establishing the motivations of patients with dementia and cognitive impairment and their carers in joining a dementia research register (DemReg) ⬇️

artículo científico publicado el 19 de marzo de 2013

Ethical challenges in preclinical Alzheimer's disease observational studies and trials: Results of the Barcelona summit

artículo científico publicado en 2016

European Prevention of Alzheimer's Dementia Registry: Recruitment and prescreening approach for a longitudinal cohort and prevention trials

artículo científico publicado en 2018

Evaluation of exercise on individuals with dementia and their carers: a randomised controlled trial

artículo científico publicado en 2010

GWAS on family history of Alzheimer's disease.

artículo científico publicado en 2018

Genetic variation in the alpha 7 nicotinic acetylcholine receptor is associated with delusional symptoms in Alzheimer's disease

artículo científico publicado en 2008

Health state values for use in the economic evaluation of treatments for Alzheimer's disease

artículo científico publicado el 1 de enero de 2012

Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial

artículo científico publicado en 2008

Is late-onset Alzheimer's disease really a disease of midlife?

artículo científico publicado en 2015

Is the effectiveness of memory assessment services associated with their structural and process characteristics?

artículo científico publicado en 2017

Latest advances on interventions that may prevent, delay or ameliorate dementia ⬇️

artículo científico publicado el 1 de mayo de 2011

Lifestyle and neurodegeneration in midlife as expressed on functional magnetic resonance imaging: A systematic review.

artículo científico publicado en 2018

Metaanalysis of randomized trials of the efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer disease

artículo científico publicado en 2004

Metal-protein attenuating compounds and Alzheimer's disease

artículo científico publicado en 2004

Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial

artículo científico publicado en 2003

Mild cognitive impairment (MCI) twenty years on ⬇️

artículo científico publicado el 1 de enero de 2012

Model-Based Economic Evaluation in Alzheimer's Disease: A Review of the Methods Available to Model Alzheimer's Disease Progression ⬇️

artículo científico publicado el 1 de julio de 2011

Models for dementia risk prediction: so much activity brings a need for coordination and clarity

scholarly article by Craig W Ritchie & Graciela Muniz-Terrera published 2 November 2018 in Journal of Neurology, Neurosurgery and Psychiatry

PBT2 rapidly improves cognition in Alzheimer's Disease: additional phase II analyses

artículo científico publicado en 2010

Participant outcomes and preferences in Alzheimer's disease clinical trials: The electronic Person-Specific Outcome Measure (ePSOM) development program

scholarly article by Stina Saunders et al published 2018 in Alzheimer's & dementia (New York, N. Y.)

Peripheral Retinal Imaging Biomarkers for Alzheimer's Disease: A Pilot Study.

artículo científico publicado en 2018

Plasma and CSF Abeta for the longitudinal prediction of Alzheimer's disease dementia and other dementias in people with cognitive decline but no dementia

artículo científico publicado en 2011

Plasma and Cerebro Spinal Fluid Amyloid Beta 42, 40 and the 42:40 ratio for diagnosis of incipient Dementia in a population with objective cognitive decline

artículo científico publicado en 2010

Plasma and Cerebro Spinal Fluid Amyloid Beta 42, 40 and the 42:40 ratio for diagnosis of incipient Dementia in a population with objective cognitive decline

artículo científico publicado en 2010

Plasma and Cerebrospinal fluid (CSF) Abeta42 for the differential diagnosis of Alzheimer's disease dementia in participants diagnosed with any dementia subtype in a specialist care setting

artículo científico publicado en 2014

Prescreening for European Prevention of Alzheimer Dementia (EPAD) trial-ready cohort: impact of AD risk factors and recruitment settings

artículo científico publicado en 2020

Prospective cohort studies in dementia

artículo científico publicado en 2013

Quantifying the Diagnostic Pathway for Patients with Cognitive Impairment: Real-World Data from Seven European and North American Countries

artículo científico publicado en 2018

Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta

artículo científico publicado en 2008

Recommended cognitive outcomes in preclinical Alzheimer's disease: Consensus statement from the European Prevention of Alzheimer's Dementia project

artículo científico publicado en 2016

Remote data collection speech analysis and prediction of the identification of Alzheimer’s disease biomarkers in people at risk for Alzheimer’s disease dementia: the Speech on the Phone Assessment (SPeAk) prospective observational study protocol

scientific article published in 2022

Reporting standards for studies of diagnostic test accuracy in dementia: The STARDdem Initiative

artículo científico publicado en 2014

Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial

artículo científico publicado en 2008

Secondary prevention of Alzheimer's dementia: neuroimaging contributions

artículo científico publicado en 2018

Systems Biology Methods for Alzheimer's Disease Research Toward Molecular Signatures, Subtypes, and Stages and Precision Medicine: Application in Cohort Studies and Trials

artículo científico publicado en 2018

The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer's disease

artículo científico publicado en 2017

The PREVENT research programme--a novel research programme to identify and manage midlife risk for dementia: the conceptual framework

artículo científico

The PREVENT study: a prospective cohort study to identify mid-life biomarkers of late-onset Alzheimer's disease ⬇️

artículo científico publicado el 19 de noviembre de 2012

The midlife cognitive profiles of adults at high risk of late-onset Alzheimer's disease: The PREVENT study

artículo científico publicado en 2017

Vascular risk factors and cognitive function among 3763 participants in the Hypertension in the Very Elderly Trial (HYVET): a cross-sectional analysis

artículo científico publicado en 2009

Lista de obras de

A composite measure of cognitive and functional progression in Alzheimer's disease: Design of the Capturing Changes in Cognition study

A novel cognitive-functional composite measure to detect changes in early Alzheimer's disease: Test-retest reliability and feasibility.

A phase 2 randomized, controlled trial of the α7 agonist ABT-126 in mild-to-moderate Alzheimer's dementia.

A randomized, double-blind, placebo-controlled trial of donepezil hydrochloride (Aricept) for reducing the incidence of postoperative delirium after elective total hip replacement

A randomized, exploratory molecular imaging study targeting amyloid β with a novel 8-OH quinoline in Alzheimer's disease: The PBT2-204 IMAGINE study

A review of clinical trial designs used to detect a disease-modifying effect of drug therapy in Alzheimer's disease and Parkinson's disease

A systematic review of biomarkers for disease progression in Alzheimer's disease

ABT-126 monotherapy in mild-to-moderate Alzheimer's dementia: randomized double-blind, placebo and active controlled adaptive trial and open-label extension

Alcohol and Alzheimer's Disease-Does Alcohol Dependence Contribute to Beta-Amyloid Deposition, Neuroinflammation and Neurodegeneration in Alzheimer's Disease?

Alcohol and Alzheimer's Disease-Does Alcohol Dependence Contribute to Beta-Amyloid Deposition, Neuroinflammation and Neurodegeneration in Alzheimer's Disease?

Alzheimer's disease in Down syndrome: An overlooked population for prevention trials

Amisulpride for very late-onset schizophrenia-like psychosis: the ATLAS three-arm RCT

An international perspective on advanced neuroimaging: cometh the hour or ivory tower?

An international perspective on advanced neuroimaging: cometh the hour or ivory tower? – Corrigendum

Antipsychotic treatment of very late-onset schizophrenia-like psychosis (ATLAS): a randomised, controlled, double-blind trial.

Aβ42/Aβ40 and Aβ42/Aβ38 Ratios Are Associated with Measures of Gait Variability and Activities of Daily Living in Mild Alzheimer's Disease: A Pilot Study

Better together for better dementia research and care

Boosting translational research on Alzheimer's disease in Europe: The Innovative Medicine Initiative AD research platform

CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)

CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).

Carer impressions of participation in Alzheimer's disease clinical trials: what are their hopes? And is it worth it?

Change in Health-related Quality of Life After Referral to Memory Assessment Services

Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology

Dementia trials and dementia tribulations: methodological and analytical challenges in dementia research

Detecting cognitive changes in preclinical Alzheimer's disease: A review of its feasibility

Development of interventions for the secondary prevention of Alzheimer's dementia: the European Prevention of Alzheimer's Dementia (EPAD) project

Establishing the motivations of patients with dementia and cognitive impairment and their carers in joining a dementia research register (DemReg) ⬇️

Ethical challenges in preclinical Alzheimer's disease observational studies and trials: Results of the Barcelona summit

European Prevention of Alzheimer's Dementia Registry: Recruitment and prescreening approach for a longitudinal cohort and prevention trials

Evaluation of exercise on individuals with dementia and their carers: a randomised controlled trial

GWAS on family history of Alzheimer's disease.

Genetic variation in the alpha 7 nicotinic acetylcholine receptor is associated with delusional symptoms in Alzheimer's disease

Health state values for use in the economic evaluation of treatments for Alzheimer's disease

Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial

Is late-onset Alzheimer's disease really a disease of midlife?

Is the effectiveness of memory assessment services associated with their structural and process characteristics?

Latest advances on interventions that may prevent, delay or ameliorate dementia ⬇️

Lifestyle and neurodegeneration in midlife as expressed on functional magnetic resonance imaging: A systematic review.

Metaanalysis of randomized trials of the efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer disease

Metal-protein attenuating compounds and Alzheimer's disease

Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial

Mild cognitive impairment (MCI) twenty years on ⬇️

Model-Based Economic Evaluation in Alzheimer's Disease: A Review of the Methods Available to Model Alzheimer's Disease Progression ⬇️

Models for dementia risk prediction: so much activity brings a need for coordination and clarity

PBT2 rapidly improves cognition in Alzheimer's Disease: additional phase II analyses

Participant outcomes and preferences in Alzheimer's disease clinical trials: The electronic Person-Specific Outcome Measure (ePSOM) development program

Peripheral Retinal Imaging Biomarkers for Alzheimer's Disease: A Pilot Study.

Plasma and CSF Abeta for the longitudinal prediction of Alzheimer's disease dementia and other dementias in people with cognitive decline but no dementia

Plasma and Cerebro Spinal Fluid Amyloid Beta 42, 40 and the 42:40 ratio for diagnosis of incipient Dementia in a population with objective cognitive decline

Plasma and Cerebro Spinal Fluid Amyloid Beta 42, 40 and the 42:40 ratio for diagnosis of incipient Dementia in a population with objective cognitive decline

Plasma and Cerebrospinal fluid (CSF) Abeta42 for the differential diagnosis of Alzheimer's disease dementia in participants diagnosed with any dementia subtype in a specialist care setting

Prescreening for European Prevention of Alzheimer Dementia (EPAD) trial-ready cohort: impact of AD risk factors and recruitment settings

Prospective cohort studies in dementia

Quantifying the Diagnostic Pathway for Patients with Cognitive Impairment: Real-World Data from Seven European and North American Countries

Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta

Recommended cognitive outcomes in preclinical Alzheimer's disease: Consensus statement from the European Prevention of Alzheimer's Dementia project

Remote data collection speech analysis and prediction of the identification of Alzheimer’s disease biomarkers in people at risk for Alzheimer’s disease dementia: the Speech on the Phone Assessment (SPeAk) prospective observational study protocol

Reporting standards for studies of diagnostic test accuracy in dementia: The STARDdem Initiative

Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial

Secondary prevention of Alzheimer's dementia: neuroimaging contributions

Systems Biology Methods for Alzheimer's Disease Research Toward Molecular Signatures, Subtypes, and Stages and Precision Medicine: Application in Cohort Studies and Trials

The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer's disease

The PREVENT research programme--a novel research programme to identify and manage midlife risk for dementia: the conceptual framework

The PREVENT study: a prospective cohort study to identify mid-life biomarkers of late-onset Alzheimer's disease ⬇️

The midlife cognitive profiles of adults at high risk of late-onset Alzheimer's disease: The PREVENT study

Vascular risk factors and cognitive function among 3763 participants in the Hypertension in the Very Elderly Trial (HYVET): a cross-sectional analysis